EUVIMEDEUVIMED entdecken
Crossref

Resolvin D2 attenuates platelet activation and thrombosis via the GPR18 receptor

Yang Ji, Maojing Wang, Pin Sun, Qing Zhao, Shanglang Cai

Biochemical and Biophysical Research Communications · 2026-06 · 819 · 153805

DOI: 10.1016/j.bbrc.2026.153805 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biochemical and Biophysical Research Communications, 2026-06. Verfasst von Yang Ji und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, The Affiliated Hospital of Qingdao University, No. 16 Jiangsu Road, Shinan District, Qingdao, Shandong, 266003, China. Hauptthemen laut MEDLINE: Receptors, G-Protein-Coupled, Docosahexaenoic Acids, Thrombosis, Platelet Activation. Die Arbeit nennt 26 Literaturangaben. Gefördert von: Natural Science Foundation of Shandong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Arterial thrombotic events, including acute coronary syndromes, remain the leading cause of morbidity and mortality worldwide. Platelet activation plays a crucial role in arterial thrombosis. The resolution of inflammation is an actively regulated physiological process driven by specialized pro-resolving mediators (SPMs). Resolvin D2 (RvD2), a core endogenous lipid mediator derived from docosahexaenoic acid (DHA), exhibits established protective effects in maintaining cardiovascular homeostasis and delaying atherosclerosis. However, the roles of RvD2 and its receptor GPR18 in platelet activation and arterial thrombosis remain largely unknown. In this study, we evaluated the effects of RvD2 on platelet activation and thrombosis using in vitro platelet function assays and an in vivo thrombosis model. In vitro assays demonstrated that RvD2 concentration-dependently (50, 100, 500 pg/mL) inhibited human platelet aggregation induced by thrombin, collagen, and ADP, and reduced ATP release induced by thrombin and collagen. RvD2 pretreatment significantly decreased the spreading area of platelets on immobilized fibrinogen and delayed clot retraction. Furthermore, the putative GPR18 antagonist O-1918 successfully abolished the RvD2-mediated inhibition of aggregation and clot retraction. Using wild-type (WT) and Gpr18 knockout (Gpr18-/-) mice, we confirmed that RvD2 exerted its inhibitory effects on aggregation and ATP release only in WT mice. In a FeCl3-induced mesenteric artery thrombosis model, intravenous administration of RvD2 (0.5 μg/kg) significantly prolonged the time to first microthrombus formation (>20 μm) and the final vessel occlusion time in WT mice, whereas this antithrombotic protection was entirely lost in Gpr18-/- mice. Finally, clinical cohort analysis of 77 patients with coronary heart disease (CHD) revealed that baseline plasma RvD2 levels were negatively correlated with ADP- and collagen-induced platelet reactivity. Our findings demonstrate that RvD2 attenuates platelet activation and thrombosis via the GPR18 receptor, and that the platelet hyperreactivity observed in patients with CHD may be associated with reduced plasma RvD2 levels.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Receptors, G-Protein-CoupledDocosahexaenoic AcidsThrombosisPlatelet ActivationAnimalsHumansSpecialized Pro-Resolving MediatorsMaleMice, Inbred C57BLMice, KnockoutMicePlatelet AggregationBlood Platelets

Stichwörter der Autor:innen

Coronary heart diseaseGPR18Platelet activationResolvin D2Specialized pro-resolving mediatorsThrombosis

Substanzen

resolvin D2Receptors, G-Protein-CoupledDocosahexaenoic Acids

Autor:innen und Institutionen

  • Department of Cardiology, The Affiliated Hospital of Qingdao University, No. 16 Jiangsu Road, Shinan District, Qingdao, Shandong, 266003, China.
  • Department of Cardiology, The Affiliated Hospital of Qingdao University, No. 16 Jiangsu Road, Shinan District, Qingdao, Shandong, 266003, China. Electronic address: caishanglang@qdu.edu.cn.

Förderung

  • Natural Science Foundation of Shandong Province

Zitieren

APA

Ji, Y., Wang, M., Sun, P., Zhao, Q., & Cai, S. (2026). Resolvin D2 attenuates platelet activation and thrombosis via the GPR18 receptor. Biochemical and Biophysical Research Communications, 819, 153805. https://doi.org/10.1016/j.bbrc.2026.153805

Vancouver

Ji Y, Wang M, Sun P, Zhao Q, Cai S. Resolvin D2 attenuates platelet activation and thrombosis via the GPR18 receptor. Biochemical and Biophysical Research Communications. 2026;819:153805. doi:10.1016/j.bbrc.2026.153805

BibTeX
@article{Ji2026,
  author = {Ji, Yang and Wang, Maojing and Sun, Pin and Zhao, Qing and Cai, Shanglang},
  title = {Resolvin D2 attenuates platelet activation and thrombosis via the GPR18 receptor},
  journal = {Biochemical and Biophysical Research Communications},
  year = {2026},
  volume = {819},
  pages = {153805},
  doi = {10.1016/j.bbrc.2026.153805}
}
Kostenlos starten →